WATERS CORP /DE/ News
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
see moreWATERS CORP /DE/ Market News
15d
Waters Corporation Rolls Out ‘AI Link’ Platform to Boost AI-Augmented LC‑MS Workflows
- Waters Corporation this week unveiled “AI Link,” an AI‑enabled platform for LC‑MS workflows, marking a tangible innovation in its instrument capabilities.
29d
Waters Corporation Schedules Q3 2026 Earnings Call for November 3
Waters Corporation (WAT) has announced its third-quarter 2026 earnings conference call for November 3, providing investors with oversight into recent performance.
21 Sep at 20:30
Waters Corporation Unveils BD FACSDiscover A7 Cell Analyzer, Expanding Flow Cytometry Portfolio
Waters launches the BD FACSDiscover A7 Cell Analyzer on September 14, 2026, marking a significant expansion into standardized spectral flow cytometry.
07 Sep at 20:30
Waters Corporation Raises Full-Year 2026 Outlook After Strong Q2 Results
Waters (NYSE: WAT) beat Q2 organic and acquisition revenue targets, prompting a boost to its full-year 2026 guidance across revenue and adjusted EPS.
24 Aug at 20:30
Waters Corporation Raises Full-Year Outlook After Q2 Beat Highlights Strength in Acquired Business
Waters (NYSE: WAT) lifted its full-year 2026 revenue and adjusted EPS guidance following a Q2 beat, driven by stronger organic growth and a faster-than-expected turnaround in its newly acquired diagnostics business.
26 Jul at 17:08
Waters Corporation's Growth Strategy Enhanced by Major Acquisition and Positive Market Trends
In recent developments, Waters Corporation (NYSE: WAT) has demonstrated significant strategic initiatives and market performance, reflecting a broader recovery in the life sciences tools and services sector.